IL6 and metabolic dysfunction-associated steatohepatitis: On the other hand, in the CHC-SF group as well as in NASH group, there were increased liver tissue levels of IL-6, IL-17A and IL-23 in comparison with plasma levels, which could represent a higher local than systemic immunology response.